Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharma Inc (Class A) | Mr. Chirag Patel | Director, President & Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2026 | 6,381,734 | 6,381,734 (4%) | 4% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Mr. Chintu Patel | Director, Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2026 | 6,381,734 | 6,381,734 (4%) | 4% | - | Class A Common Stock | |
| Life Time Grp Holdings Inc | Mr. John G. Danhakl | Director | Sale of securities on an exchange or to another person at price $ 43.16 per share. | 10 Aug 2026 | 5,119,099 | 5,908,604 | - | 43.2 | 220,940,313 | Common Stock |
| Life Time Grp Holdings Inc | Mr. J. Kristofer Galashan | Director | Sale of securities on an exchange or to another person at price $ 43.16 per share. | 10 Aug 2026 | 5,119,099 | 5,908,604 | - | 43.2 | 220,940,313 | Common Stock |
| Latigo Biotherapeutics Inc | Dr. Beth C. Seidenberg,M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 3,547,842 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Latigo Biotherapeutics Inc | Dr. Beth C. Seidenberg,M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 3,547,842 | 4,916,374 | - | - | Common Stock | ||
| Latigo Biotherapeutics Inc | Dr. Beth C. Seidenberg,M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 3,464,072 | 0 | - | - | Series A-2 Convertible Preferred Stock | ||
| Latigo Biotherapeutics Inc | Dr. Beth C. Seidenberg,M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 3,464,072 | 3,510,927 | - | - | Common Stock | ||
| Latigo Biotherapeutics Inc | Mr. James Tananbaum, M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 3,117,664 | 3,117,664 | - | - | Common Stock | ||
| Latigo Biotherapeutics Inc | Mr. James Tananbaum, M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 3,117,664 | 0 | - | - | Series A-2 Convertible Preferred Stock | ||
| Latigo Biotherapeutics Inc | Mr. James Tananbaum, M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 3,117,664 | 0 | - | - | Series A-2 Convertible Stock | ||
| Latigo Biotherapeutics Inc | Mr. James Tananbaum, M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 3,117,664 | 3,117,664 | - | - | Common Stock | ||
| Silence Therapeutics PLC (ADR) | Mr. Richard Ian Griffiths | Ten Percent Owner | 10 Aug 2026 | 2,792,826 | 7,488,660 | - | - | American Depositary Shares | ||
| Figma Inc Ordinary Shares | Mr. Daniel Hiller Rimer | Director | Other type of transaction at price $ 0.00 per share. | 10 Aug 2026 | 2,758,691 | 50,293,428 | - | - | Class A Common Stock | |
| Latigo Biotherapeutics Inc | Dr. Beth C. Seidenberg,M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 2,066,857 | 0 | - | - | Series A-2 Convertible Preferred Stock | ||
| Latigo Biotherapeutics Inc | Dr. Beth C. Seidenberg,M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 2,066,857 | 2,094,813 | - | - | Common Stock | ||
| Agenus Inc | Dr. Garo H. Armen, PhD | Director, See Remarks | 10 Aug 2026 | 1,971,500 | 1,971,500 | - | - | Stock Option | ||
| Pacific Biosciences of California Inc | Mr. Oene Mark Van | See Remarks | 10 Aug 2026 | 1,967,888 | 1,967,888 | - | - | Stock Option (right to buy) | ||
| Sonida Senior Living Inc | Mr. Michael Simanovsky | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Aug 2026 | 1,504,134 | 5,353,689 (17%) | 4% | - | Common Stock | |
| Sonida Senior Living Inc | Mr. Michael Simanovsky | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.00 per share. | 10 Aug 2026 | 1,504,134 | 6,857,823 (21%) | 4% | 32 | 48,132,288 | Common Stock |
| Latigo Biotherapeutics Inc | Dr. Beth C. Seidenberg,M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 1,484,401 | 4,995,328 | - | - | Common Stock | ||
| Latigo Biotherapeutics Inc | Dr. Beth C. Seidenberg,M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 1,484,401 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Erasca Inc | Dr. Charles S. Fuchs, M.D.,M.P.H. | President, R&D | 10 Aug 2026 | 1,300,000 | 1,300,000 | - | - | Stock option (right to buy) | ||
| Latigo Biotherapeutics Inc | Mr. James Tananbaum, M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 1,125,823 | 0 | - | - | Series A-2 Convertible Preferred Stock | ||
| Latigo Biotherapeutics Inc | Mr. James Tananbaum, M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 1,125,823 | 1,125,823 | - | - | Common Stock | ||
| BlossomHill Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 10 Aug 2026 | 1,049,283 | 2,089,279 | - | - | Common Stock | ||
| BlossomHill Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 10 Aug 2026 | 1,049,283 | 0 | - | - | Series B Preferred Stock | ||
| BlossomHill Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 10 Aug 2026 | 1,039,996 | 1,039,996 | - | - | Common Stock | ||
| BlossomHill Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 10 Aug 2026 | 1,039,996 | 0 | - | - | Series A Preferred Stock | ||
| Latigo Biotherapeutics Inc | Dr. Beth C. Seidenberg,M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 1,027,635 | 0 | - | - | Series A-2 Convertible Preferred Stock | ||
| Latigo Biotherapeutics Inc | Dr. Beth C. Seidenberg,M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 1,027,635 | 5,944,009 | - | - | Common Stock | ||
| Crawford & Co. (Class A) | Mr. Jesse C. Crawford, Sr | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.81 per share. | 10 Aug 2026 | 1,000,000 | 4,447,188 (14%) | 3% | 12.8 | 12,813,700 | Class A Common Stock |
| Latigo Biotherapeutics Inc | Dr. Beth C. Seidenberg,M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 938,979 | 1,368,532 | - | - | Common Stock | ||
| Latigo Biotherapeutics Inc | Dr. Beth C. Seidenberg,M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 938,979 | 0 | - | - | Series Seed Convertible Stock | ||
| B&G Foods Inc | Mr. Robert D. Mills | Director, President & CEO | 10 Aug 2026 | 900,000 | 900,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Silence Therapeutics PLC (ADR) | Mr. Richard Ian Griffiths | Ten Percent Owner | 10 Aug 2026 | 800,000 | 6,535,160 | - | - | American Depositary Shares | ||
| Latigo Biotherapeutics Inc | Mr. James Tananbaum, M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 742,201 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Latigo Biotherapeutics Inc | Mr. James Tananbaum, M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 742,201 | 1,868,024 | - | - | Common Stock | ||
| Figma Inc Ordinary Shares | Mr. Daniel Hiller Rimer | Director | Other type of transaction at price $ 0.00 per share. | 10 Aug 2026 | 703,594 | 0 | - | - | Class A Common Stock | |
| BlossomHill Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 10 Aug 2026 | 625,000 | 2,714,279 | - | 16 | 10,000,000 | Common Stock |
| Silence Therapeutics PLC (ADR) | Mr. Richard Ian Griffiths | Ten Percent Owner | 10 Aug 2026 | 605,174 | 5,077,166 | - | - | American Depositary Shares | ||
| Pacific Biosciences of California Inc | Mr. Oene Mark Van | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2026 | 489,130 | 2,732,764 (1%) | 0% | 0 | Common Stock | |
| Silence Therapeutics PLC (ADR) | Mr. Richard Ian Griffiths | Ten Percent Owner | 10 Aug 2026 | 470,820 | 5,682,340 | - | - | American Depositary Shares | ||
| Latigo Biotherapeutics Inc | Mr. James Tananbaum, M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 445,320 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Latigo Biotherapeutics Inc | Mr. James Tananbaum, M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 445,320 | 3,562,984 | - | - | Common Stock | ||
| Jewett-Cameron Trading Co. Ltd | Mr. Scott Kotarba | Director, Ten Percent Owner | 10 Aug 2026 | 386,522 | 738,534 | - | - | Purchase Option (right to buy) | ||
| Silence Therapeutics PLC (ADR) | Mr. Richard Ian Griffiths | Ten Percent Owner | 10 Aug 2026 | 382,000 | 6,153,160 | - | - | American Depositary Shares | ||
| Alignment Healthcare Inc | Mr. John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.88 per share. | 10 Aug 2026 | 298,000 | 790,766 | - | 13.9 | 4,136,776 | Common Stock |
| Garmin | Mr. Jonathan C. Burrell | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 298,000 | 298,000 (0%) | 0% | 0 | Registered Shares | |
| Garmin | Mr. Jonathan C. Burrell | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 298,000 | 4,073,752 (2%) | 0% | 0 | Registered Shares | |
| Latigo Biotherapeutics Inc | Mr. James Tananbaum, M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 296,880 | 3,414,544 | - | - | Common Stock | ||
| Latigo Biotherapeutics Inc | Mr. James Tananbaum, M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 296,880 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Palantir | Mr. Shyam Sankar | See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 294,502 | 292,786 | - | 0 | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Mr. Gautam Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2026 | 283,632 | 283,632 (0%) | 0% | - | Class A Common Stock | |
| Intuitive Machines Inc (Class A) | Dr. Kamal Seyed Ghaffarian, PhD | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2026 | 267,448 | 3,762,216 | - | - | Class A Common Stock | |
| Intuitive Machines Inc (Class A) | Dr. Kamal Seyed Ghaffarian, PhD | Director, Ten Percent Owner | 10 Aug 2026 | 267,448 | 34,362,449 | - | - | Common Units | ||
| Intuitive Machines Inc (Class A) | Dr. Kamal Seyed Ghaffarian, PhD | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Aug 2026 | 267,448 | 34,362,449 | - | - | Class C Common Stock | |
| GCI Liberty Inc - Ordinary Shares - Series A | Dr. John C. Malone, B.S.,M.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 25.08 per share. | 10 Aug 2026 | 259,680 | 2,276,200 | - | 25.1 | 6,512,826 | Series C GCI Group Common Stock |
| Intuitive Machines Inc (Class A) | Dr. Kamal Seyed Ghaffarian, PhD | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.13 per share. | 10 Aug 2026 | 248,784 | 3,513,432 | - | 16.1 | 4,013,831 | Class A Common Stock |
| Cytek BioSciences Inc | Mr. Ilan Feuchtwang | Chief Legal Officer, Secretary | 10 Aug 2026 | 241,416 | 241,416 | - | - | Restricted Stock Units | ||
| Insmed Inc | Mr. Roger Adsett | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 133.27 per share. | 10 Aug 2026 | 239,850 | 98,744 (0%) | 0% | 133.3 | 31,964,810 | Common Stock |
| Dave & Buster`s Entertainment Inc | Mr. Darin E. Harper | Chief Executive Officer | 10 Aug 2026 | 228,426 | 228,426 | - | - | Stock Option (Right to Buy) | ||
| Dave & Buster`s Entertainment Inc | Mr. Darin E. Harper | Chief Executive Officer | 10 Aug 2026 | 228,426 | 228,426 | - | - | Performance Shares SSS | ||
| McCormick & Company | Mr. Lawrence E. Kurzius | Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.02 per share. | 10 Aug 2026 | 205,538 | 502,530 (5%) | 2% | 49.0 | 10,076,500 | Common Stock - Voting |
| McCormick & Company | Mr. Lawrence E. Kurzius | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 52.69 per share. | 10 Aug 2026 | 205,538 | 296,992 (3%) | 2% | 52.7 | 10,829,201 | Common Stock - Voting |
| McCormick & Company | Mr. Lawrence E. Kurzius | Ten Percent Owner | 10 Aug 2026 | 205,538 | 0 | - | - | Options - Right to Buy | ||
| Dave & Buster`s Entertainment Inc | Mr. Darin E. Harper | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2026 | 203,046 | 309,952 (1%) | 0% | 0 | Common Stock | |
| Warner Bros. (Class A) | Mr. Gerhard Zeiler | President, International | Sale of securities on an exchange or to another person at price $ 27.07 per share. | 10 Aug 2026 | 201,656 | 537,436 (0%) | 0% | 27.1 | 5,458,828 | Series A Common Stock |
| Warner Bros. (Class A) | Mr. Gerhard Zeiler | President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.02 per share. | 10 Aug 2026 | 201,656 | 739,092 (0%) | 0% | 15.0 | 3,028,873 | Series A Common Stock |
| Warner Bros. (Class A) | Mr. Gerhard Zeiler | President, International | 10 Aug 2026 | 201,656 | 0 | - | - | Employee Stock Option (right to acquire) | ||
| Mueller Ind Inc | Mr. Gregory L. Christopher | Director, Chairman of the Board & CEO | Sale of securities on an exchange or to another person at price $ 68.44 per share. | 10 Aug 2026 | 200,000 | 1,598,850 (2%) | 0% | 68.4 | 13,688,400 | Common Stock |
| NOW Inc | Mr. David A. Cherechinsky | Director, President and CEO | 10 Aug 2026 | 198,213 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| NOW Inc | Mr. David A. Cherechinsky | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.73 per share. | 10 Aug 2026 | 198,213 | 1,163,864 (1%) | 0% | 16.7 | 3,316,103 | Common stock |
| NOW Inc | Mr. David A. Cherechinsky | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.26 per share. | 10 Aug 2026 | 198,213 | 1,362,077 (1%) | 0% | 10.3 | 2,033,665 | Common stock |
| Warner Bros. (Class A) | Mr. Gerhard Zeiler | President, International | Sale of securities on an exchange or to another person at price $ 27.04 per share. | 10 Aug 2026 | 196,691 | 537,436 (0%) | 0% | 27.0 | 5,318,525 | Series A Common Stock |
| Warner Bros. (Class A) | Mr. Gerhard Zeiler | President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.67 per share. | 10 Aug 2026 | 196,691 | 734,127 (0%) | 0% | 8.7 | 1,705,311 | Series A Common Stock |
| Warner Bros. (Class A) | Mr. Gerhard Zeiler | President, International | 10 Aug 2026 | 196,691 | 101,326 | - | - | Employee Stock Option (right to acquire) | ||
| Latigo Biotherapeutics Inc | Mr. James Tananbaum, M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 195,776 | 2,203,800 | - | - | Common Stock | ||
| Latigo Biotherapeutics Inc | Mr. James Tananbaum, M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 195,776 | 0 | - | - | Convertible Promissory Note | ||
| Coupang Inc (Class A) | Mr. Harold Rogers | See Remarks | Sale of securities on an exchange or to another person at price $ 16.18 per share. | 10 Aug 2026 | 192,110 | 740,931 | - | 16.2 | 3,107,975 | Class A Common Stock |
| GoodRx Holdings Inc (Class A) | Mr. Justin Fengler | See Remarks | 10 Aug 2026 | 190,204 | 190,204 | - | - | Restricted Stock Unit | ||
| Sight Sciences Inc | Mr. Kashif Rashid | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2026 | 181,818 | 181,818 | - | 0 | Common Stock | |
| Jewett-Cameron Trading Co. Ltd | Mr. Scott Kotarba | Director, Ten Percent Owner | 10 Aug 2026 | 176,006 | 176,006 | - | - | Obligation to Buy (Initial Purchase) | ||
| Jewett-Cameron Trading Co. Ltd | Mr. Scott Kotarba | Director, Ten Percent Owner | 10 Aug 2026 | 176,006 | 352,012 | - | - | Purchase Option (right to buy) | ||
| Annexon Inc | Dr. Mark S. Blumenkranz, M.D. | Director | 10 Aug 2026 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | ||
| Encompass Health Corp | Mr. Mark J. Tarr | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 125.46 per share. | 10 Aug 2026 | 171,569 | 269,393 (0%) | 0% | 125.5 | 21,525,047 | Encompass Health Common Stock |
| Latigo Biotherapeutics Inc | Dr. Beth C. Seidenberg,M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 165,519 | 0 | - | - | Convertible Promissory Note | ||
| Latigo Biotherapeutics Inc | Dr. Beth C. Seidenberg,M.D. | Director, Ten Percent Owner | 10 Aug 2026 | 165,519 | 5,160,847 | - | - | Common Stock | ||
| Aeva Tech Inc | Mr. Soroush Salehian Dardashti | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 23.87 per share. | 10 Aug 2026 | 149,961 | 1,320,847 | - | 23.9 | 3,579,449 | Common Stock |
| GCI Liberty Inc - Ordinary Shares - Series A | Dr. John C. Malone, B.S.,M.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 24.51 per share. | 10 Aug 2026 | 147,050 | 2,423,250 | - | 24.5 | 3,603,578 | Series C GCI Group Common Stock |
| CoreWeave Inc (Class A) | Mr. Brannin McBee | Chief Development Officer | 10 Aug 2026 | 144,000 | 5,610,894 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Mr. Brannin McBee | Chief Development Officer | 10 Aug 2026 | 144,000 | 467,263 | - | - | Class A Common Stock | ||
| Latigo Biotherapeutics Inc | Mr. James Tananbaum, M.D. | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 10 Aug 2026 | 140,000 | 2,008,024 | - | 18 | 2,520,000 | Common Stock |
| B&G Foods Inc | Mr. Robert D. Mills | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2026 | 134,408 | 234,064 (0%) | 0% | 0 | Common Stock | |
| Central Garden & Pet Co. | Mr. William E. Brown | Director, Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.18 per share. | 10 Aug 2026 | 127,942 | 1,065,490 (2%) | 0% | 31.2 | 3,988,720 | Class A Common Stock |
| Central Garden & Pet Co. | Mr. William E. Brown | Director, Chairman, Ten Percent Owner | 10 Aug 2026 | 127,942 | 0 | - | - | Stock Option | ||
| Cytek BioSciences Inc | Mr. Ilan Feuchtwang | Chief Legal Officer, Secretary | 10 Aug 2026 | 127,118 | 127,118 | - | - | Employee Stock Option (right to buy) | ||
| Silence Therapeutics PLC (ADR) | Mr. Richard Ian Griffiths | Ten Percent Owner | 10 Aug 2026 | 120,000 | 4,957,166 | - | - | American Depositary Shares | ||
| Central Garden & Pet Co. | Mr. William E. Brown | Director, Chairman, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.28 per share. | 10 Aug 2026 | 116,232 | 949,258 (2%) | 0% | 38.3 | 4,449,361 | Class A Common Stock |
| biote Corp (Class A) | Mr. Marc D. Beer | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 1.53 per share. | 10 Aug 2026 | 115,950 | 223,744 | - | 1.5 | 177,404 | Class A Common Stock |
| 908 Devices Inc | Dr. Kevin J. Knopp, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 9.83 per share. | 10 Aug 2026 | 115,748 | 616,507 | - | 9.8 | 1,137,803 | Common Stock |
| Twist Bioscience Corp | Dr. Emily M. Leproust, PhD | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.66 per share. | 10 Aug 2026 | 113,318 | 932,256 (2%) | 0% | 26.7 | 3,021,058 | Common Stock |
| Twist Bioscience Corp | Dr. Emily M. Leproust, PhD | Director, Chief Executive Officer | 10 Aug 2026 | 113,318 | 153,221 | - | - | Employee Stock Option (right to buy) | ||
| Twist Bioscience Corp | Dr. Emily M. Leproust, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 125.16 per share. | 10 Aug 2026 | 113,318 | 818,938 (2%) | 0% | 125.2 | 14,183,051 | Common Stock |
| Vistance Networks Inc | Mr. L. William Krause | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 102,300 | 274,507 (0%) | 0% | 0 | Common Stock | |
| Roblox Corp (Class A) | Mr. Anthony P. Lee | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 100,000 | 6,157,311 | - | 0 | Class A Common Stock | |
| American Assets Trust Inc | Mr. Ernest S. Rady | Director, Executive Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 22.52 per share. | 10 Aug 2026 | 100,000 | 8,652,531 (14%) | 0% | 22.5 | 2,252,000 | Common Stock, par value $0.01 |
| Silence Therapeutics PLC (ADR) | Mr. Richard Ian Griffiths | Ten Percent Owner | 10 Aug 2026 | 100,000 | 4,797,166 | - | - | American Depositary Shares | ||
| Silence Therapeutics PLC (ADR) | Mr. Richard Ian Griffiths | Ten Percent Owner | 10 Aug 2026 | 100,000 | 7,388,660 | - | - | American Depositary Shares | ||
| Savers Value Village Inc | Mr. Mark Walsh | Director, CEO & Director | Sale of securities on an exchange or to another person at price $ 12.20 per share. | 10 Aug 2026 | 100,000 | 47,363 | - | 12.2 | 1,220,360 | Common Stock |
| Warner Bros. (Class A) | Mr. Gerhard Zeiler | President, International | Sale of securities on an exchange or to another person at price $ 27.06 per share. | 10 Aug 2026 | 100,000 | 537,436 (0%) | 0% | 27.1 | 2,706,000 | Series A Common Stock |
| Sonida Senior Living Inc | Mr. Michael Simanovsky | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.00 per share. | 10 Aug 2026 | 97,371 | 807,115 (2%) | 0% | 32 | 3,115,872 | Common Stock |
| Sonida Senior Living Inc | Mr. Michael Simanovsky | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Aug 2026 | 97,371 | 709,744 (2%) | 0% | - | Common Stock | |
| American Assets Trust Inc | Mr. Ernest S. Rady | Director, Executive Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 22.45 per share. | 10 Aug 2026 | 93,243 | 8,552,531 (14%) | 0% | 22.4 | 2,093,305 | Common Stock, par value $0.01 |
| Warner Bros. (Class A) | Mr. Gerhard Zeiler | President, International | Sale of securities on an exchange or to another person at price $ 27.02 per share. | 10 Aug 2026 | 92,691 | 537,436 (0%) | 0% | 27.0 | 2,504,511 | Series A Common Stock |
| Warner Bros. (Class A) | Mr. Gerhard Zeiler | President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.02 per share. | 10 Aug 2026 | 92,691 | 630,127 (0%) | 0% | 11.0 | 1,021,455 | Series A Common Stock |
| Warner Bros. (Class A) | Mr. Gerhard Zeiler | President, International | 10 Aug 2026 | 92,691 | 188,193 | - | - | Employee Stock Option | ||
| Savers Value Village Inc | Mr. Mark Walsh | Director, CEO & Director | Sale of securities on an exchange or to another person at price $ 11.93 per share. | 10 Aug 2026 | 92,059 | 47,363 | - | 11.9 | 1,097,905 | Common Stock |
| Garmin | Mr. Jonathan C. Burrell | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 90,000 | 2,043,300 (1%) | 0% | 0 | Registered Shares | |
| Garmin | Mr. Jonathan C. Burrell | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 90,000 | 716,043 (0%) | 0% | 0 | Registered Shares | |
| Accelerant Holdings (Class A) | Mr. Francis James O’Neill | Co-Founder, Chief U/W Officer | Sale of securities on an exchange or to another person at price $ 12.41 per share. | 10 Aug 2026 | 89,219 | 6,369,290 | - | 12.4 | 1,107,217 | Class A Common Shares |
| Clover Health Investments Corp (Class A) | Mr. Andrew Toy | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.65 per share. | 10 Aug 2026 | 87,798 | 9,459,316 | - | 4.7 | 408,261 | Class A Common Stock |
| Stride Inc | Mr. Robert E. Knowling, Jr | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2026 | 87,249 | 93,800 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Mr. Roger Adsett | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.67 per share. | 10 Aug 2026 | 82,280 | 181,024 (0%) | 0% | 13.7 | 1,124,768 | Common Stock |
| Insmed Inc | Mr. Roger Adsett | Chief Operating Officer | 10 Aug 2026 | 82,280 | 0 | - | - | Stock Option (right to buy) | ||
| Insmed Inc | Mr. Roger Adsett | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.46 per share. | 10 Aug 2026 | 80,970 | 338,594 (0%) | 0% | 30.5 | 2,466,346 | Common Stock |
| Insmed Inc | Mr. Roger Adsett | Chief Operating Officer | 10 Aug 2026 | 80,970 | 0 | - | - | Stock Option (right to buy) | ||
| Honest Co Inc (The ) | Mr. Jonathan Mayle | SVP, Customer Sales | Sale of securities on an exchange or to another person at price $ 5.22 per share. | 10 Aug 2026 | 79,000 | 370,155 | - | 5.2 | 412,380 | Common Stock |
| Insmed Inc | Mr. Roger Adsett | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.16 per share. | 10 Aug 2026 | 76,600 | 257,624 (0%) | 0% | 17.2 | 1,314,456 | Common Stock |
| Insmed Inc | Mr. Roger Adsett | Chief Operating Officer | 10 Aug 2026 | 76,600 | 0 | - | - | Stock Option (right to buy) | ||
| Guardant Health Inc | Dr. AmirAli Talasaz, PhD | Director, Co-Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 75,000 | 1,824,351 (1%) | 0% | 0 | Common Stock | |
| Guardant Health Inc | Dr. AmirAli Talasaz, PhD | Director, Co-Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 75,000 | 75,000 (0%) | 0% | 0 | Common Stock | |
| Sprinklr Inc (Class A) | Mr. Jacob Scott | GENERAL COUNSEL AND CORP. SEC. | Sale of securities on an exchange or to another person at price $ 6.97 per share. | 10 Aug 2026 | 71,585 | 576,827 | - | 7.0 | 498,947 | Class A Common Stock |
| Mueller Ind Inc | Mr. Gregory L. Christopher | Director, Chairman of the Board & CEO | Sale of securities on an exchange or to another person at price $ 69.08 per share. | 10 Aug 2026 | 70,000 | 70,000 (0%) | 0% | 69.1 | 4,835,950 | Common Stock |
| Mueller Ind Inc | Mr. Gregory L. Christopher | Director, Chairman of the Board & CEO | Sale of securities on an exchange or to another person at price $ 69.43 per share. | 10 Aug 2026 | 70,000 | 75,040 (0%) | 0% | 69.4 | 4,859,960 | Common Stock |
| GCI Liberty Inc - Ordinary Shares - Series A | Dr. John C. Malone, B.S.,M.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 25.22 per share. | 10 Aug 2026 | 68,800 | 2,492,050 | - | 25.2 | 1,735,452 | Series C GCI Group Common Stock |
| Butterfly Network Inc (Class A) | Mr. Joseph M. Devivo | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 10 Aug 2026 | 68,346 | 7,603,700 | - | 10.0 | 684,075 | Class A Common Stock |
| Axogen Inc | Mr. Marc A. Began | EVP & General Counsel | 10 Aug 2026 | 67,500 | 22,500 | - | - | Employee Stock Option (right to buy) | ||
| Axogen Inc | Mr. Marc A. Began | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 47.35 per share. | 10 Aug 2026 | 67,500 | 50,135 (0%) | 0% | 47.3 | 3,195,788 | Common Stock |
| Axogen Inc | Mr. Marc A. Began | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.16 per share. | 10 Aug 2026 | 67,500 | 117,635 (0%) | 0% | 8.2 | 550,800 | Common Stock |
| GCI Liberty Inc - Ordinary Shares - Series A | Dr. John C. Malone, B.S.,M.A.,PhD | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 25.57 per share. | 10 Aug 2026 | 66,702 | 2,558,752 | - | 25.6 | 1,705,624 | Series C GCI Group Common Stock |
| Protagonist Therapeutics Inc | Dr. Dinesh V. Patel, PhD | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.58 per share. | 10 Aug 2026 | 65,761 | 589,239 (2%) | 0% | 21.6 | 1,419,122 | Common Stock |
| Protagonist Therapeutics Inc | Dr. Dinesh V. Patel, PhD | Director, President and CEO | 10 Aug 2026 | 65,761 | 159,239 | - | - | Stock Option (right to buy) | ||
| Protagonist Therapeutics Inc | Dr. Dinesh V. Patel, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 149.11 per share. | 10 Aug 2026 | 65,761 | 523,478 (1%) | 0% | 149.1 | 9,805,623 | Common Stock |
| Aeva Tech Inc | Mr. Soroush Salehian Dardashti | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 24.28 per share. | 10 Aug 2026 | 64,030 | 1,256,817 | - | 24.3 | 1,554,873 | Common Stock |
| Accelerant Holdings (Class A) | Mr. Francis James O’Neill | Co-Founder, Chief U/W Officer | Sale of securities on an exchange or to another person at price $ 12.07 per share. | 10 Aug 2026 | 63,616 | 6,458,509 | - | 12.1 | 767,667 | Class A Common Shares |
| Immunome Inc | Mr. Isaac Barchas, J.D. | Director | Sale of securities on an exchange or to another person at price $ 26.23 per share. | 10 Aug 2026 | 62,291 | 0 | - | 26.2 | 1,633,893 | Common Stock |
| DiaMedica Therapeutics Inc | Mr. Dietrich John Pauls | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2026 | 60,200 | 128,791 (0%) | 0% | 0 | Voting Common Shares, no par value per share | |
| Silence Therapeutics PLC (ADR) | Mr. Richard Ian Griffiths | Ten Percent Owner | 10 Aug 2026 | 60,000 | 4,897,166 | - | - | American Depositary Shares | ||
| Cintas | Mr. Todd M. Schneider | Director, CEO and Director | Grant, award, or other acquisition of securities at price $ 202.71 per share. | 10 Aug 2026 | 57,944 | 727,006 (0%) | 0% | 202.7 | 11,745,828 | Common Stock |
| NOW Inc | Mr. David A. Cherechinsky | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.73 per share. | 10 Aug 2026 | 57,929 | 1,163,864 (1%) | 0% | 16.7 | 969,152 | Common stock |
| NOW Inc | Mr. David A. Cherechinsky | Director, President and CEO | 10 Aug 2026 | 57,929 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| NOW Inc | Mr. David A. Cherechinsky | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.53 per share. | 10 Aug 2026 | 57,929 | 1,221,793 (1%) | 0% | 9.5 | 552,063 | Common stock |
| ProFrac Holding Corp (Class A) | Mr. Matthew D. Wilks | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.86 per share. | 10 Aug 2026 | 57,519 | 479,616 | - | 4.9 | 279,485 | Class A common stock, par value $0.01 per share |
| Procore Tech Inc | Mr. Craig F. Courtemanche, Jr | Director, Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 10 Aug 2026 | 56,122 | 975,826 | - | 2.4 | 135,815 | Common Stock |
| Procore Tech Inc | Mr. Craig F. Courtemanche, Jr | Director, Chairman of the Board | 10 Aug 2026 | 56,122 | 112,244 | - | - | Stock Option (Right to Buy) | ||
| Figma Inc Ordinary Shares | Mr. Daniel Hiller Rimer | Director | Other type of transaction at price $ 0.00 per share. | 10 Aug 2026 | 55,684 | 1,015,167 | - | - | Class A Common Stock | |
| Palantir | Mr. Shyam Sankar | See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 55,498 | 587,288 | - | 0 | Class A Common Stock | |
| Accel Entertainment Inc (Class A1) | Mr. Mark T. Phelan | President and CEO | 10 Aug 2026 | 55,229 | 55,229 | - | - | Performance-based Restricted Stock Unit (PSU) | ||
| Aeva Tech Inc | Mr. Mina Rezk | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 23.81 per share. | 10 Aug 2026 | 54,860 | 1,651,809 | - | 23.8 | 1,306,469 | Common Stock |
| Datadog Inc (Class A) | Mr. Alexis Le-Quoc | Director, Chief Technology Officer | 10 Aug 2026 | 53,912 | 2,281,640 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Mr. Brannin McBee | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 89.70 per share. | 10 Aug 2026 | 53,138 | 366,781 | - | 89.7 | 4,766,553 | Class A Common Stock |
| Bausch + Lomb Corp | Mr. Frederick J. Munsch | SVP, Controller and CAO | Sale of securities on an exchange or to another person at price $ 16.78 per share. | 10 Aug 2026 | 52,900 | 45,831 | - | 16.8 | 887,662 | Common Shares, No Par Value |
| Nextracker Inc (Class A) | Mr. Daniel S. Shugar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 103.24 per share. | 10 Aug 2026 | 51,779 | 872,291 | - | 103.2 | 5,345,664 | Common Stock |
| Aptiv | Mr. Kevin P. Clark | Director, Chair and CEO | Purchase of securities on an exchange or from another person at price $ 48.89 per share. | 10 Aug 2026 | 51,190 | 651,016 (0%) | 0% | 48.9 | 2,502,684 | Ordinary Shares |
| Dave & Buster`s Entertainment Inc | Mr. Cory Hatton | Interim CFO | 10 Aug 2026 | 50,761 | 50,761 | - | - | Stock Option (Right to Buy) | ||
| Dave & Buster`s Entertainment Inc | Mr. Cory Hatton | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2026 | 50,761 | 100,475 (0%) | 0% | 0 | Common Stock | |
| Dave & Buster`s Entertainment Inc | Mr. Aldo Rosales | Chief Strategy & Revenue Ofc | 10 Aug 2026 | 50,761 | 50,761 | - | - | Performance Shares SSS | ||
| Dave & Buster`s Entertainment Inc | Mr. Aldo Rosales | Chief Strategy & Revenue Ofc | 10 Aug 2026 | 50,761 | 50,761 | - | - | Stock Option (Right to Buy) | ||
| Dave & Buster`s Entertainment Inc | Mr. Aldo Rosales | Chief Strategy & Revenue Ofc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2026 | 50,761 | 104,591 (0%) | 0% | 0 | Common Stock | |
| NOW Inc | Mr. Mark B. Johnson | See Remarks | 10 Aug 2026 | 50,181 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| NOW Inc | Mr. Mark B. Johnson | See Remarks | Sale of securities on an exchange or to another person at price $ 16.79 per share. | 10 Aug 2026 | 50,181 | 290,220 (0%) | 0% | 16.8 | 842,539 | Common stock |
| NOW Inc | Mr. Mark B. Johnson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.26 per share. | 10 Aug 2026 | 50,181 | 340,401 (0%) | 0% | 10.3 | 514,857 | Common stock |
| Citizens Inc (Class A) | Mr. Jon Stenberg | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 3.99 per share. | 10 Aug 2026 | 50,000 | 377,574 (0%) | 0% | 4.0 | 199,630 | Citizens, Inc. Class A Common Stock |
| Roblox Corp (Class A) | Mr. Anthony P. Lee | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 50,000 | 306,768 | - | 0 | Class A Common Stock | |
| Roblox Corp (Class A) | Mr. Anthony P. Lee | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 50,000 | 306,768 | - | 0 | Class A Common Stock | |
| Brilliant Earth Grp Inc (Class A) | Mr. Gavin M. Turner | Director, Ten Percent Owner | 10 Aug 2026 | 50,000 | 31,848,071 | - | - | Class B Common Stock | ||
| Brilliant Earth Grp Inc (Class A) | Mr. Gavin M. Turner | Director, Ten Percent Owner | 10 Aug 2026 | 50,000 | 31,848,071 | - | - | LLC Units | ||
| Brilliant Earth Grp Inc (Class A) | Mr. Gavin M. Turner | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.29 per share. | 10 Aug 2026 | 50,000 | 0 | - | 1.3 | 64,350 | Class A Common Stock |
| Brilliant Earth Grp Inc (Class A) | Mr. Gavin M. Turner | Director, Ten Percent Owner | 10 Aug 2026 | 50,000 | 50,000 | - | - | Class A Common Stock | ||
| Silence Therapeutics PLC (ADR) | Mr. Richard Ian Griffiths | Ten Percent Owner | 10 Aug 2026 | 50,000 | 7,338,660 | - | - | American Depositary Shares | ||
| Savers Value Village Inc | Mr. Mark Walsh | Director, CEO & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 10 Aug 2026 | 50,000 | 97,363 | - | 1.4 | 70,500 | Common Stock |
| Savers Value Village Inc | Mr. Mark Walsh | Director, CEO & Director | 10 Aug 2026 | 50,000 | 660,395 | - | - | Stock Options (Right to Purchase) | ||
| Savers Value Village Inc | Mr. Mark Walsh | Director, CEO & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.16 per share. | 10 Aug 2026 | 50,000 | 139,422 | - | 3.2 | 158,000 | Common Stock |
| Savers Value Village Inc | Mr. Mark Walsh | Director, CEO & Director | 10 Aug 2026 | 50,000 | 582,859 | - | - | Stock Options (Right to Purchase) | ||
| Savers Value Village Inc | Mr. Mark Walsh | Director, CEO & Director | 10 Aug 2026 | 50,000 | 710,395 | - | - | Stock Options (Right to Purchase) | ||
| Savers Value Village Inc | Mr. Mark Walsh | Director, CEO & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.16 per share. | 10 Aug 2026 | 50,000 | 147,363 | - | 3.2 | 158,000 | Common Stock |
| Galaxy Digital Inc (Class A) | Mr. Christopher Ferraro | President and CIO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.83 per share. | 10 Aug 2026 | 50,000 | 908,292 | - | 4.8 | 241,500 | - |
| Galaxy Digital Inc (Class A) | Mr. Christopher Ferraro | President and CIO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.83 per share. | 10 Aug 2026 | 50,000 | 908,292 | - | 4.8 | 241,500 | - |
| LifeStance Health Grp Inc | Ms. Lisa K. Miller | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.85 per share. | 10 Aug 2026 | 47,912 | 281,289 | - | 10.8 | 519,845 | Common Stock |
| CoreWeave Inc (Class A) | Mr. Brannin McBee | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 88.70 per share. | 10 Aug 2026 | 47,344 | 419,919 | - | 88.7 | 4,199,517 | Class A Common Stock |
| Stride Inc | Mr. Robert E. Knowling, Jr | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2026 | 46,741 | 140,541 (0%) | 0% | 0 | Common Stock | |
| Park Aerospace Corp | Mr. Brian E. Shore | Director, Board Chairman & CEO | Sale of securities on an exchange or to another person at price $ 37.32 per share. | 10 Aug 2026 | 46,250 | 621,369 (3%) | 0% | 37.3 | 1,725,879 | Common Stock |
| BeiGene Ltd (ADR) | Mr. John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 358.70 per share. | 10 Aug 2026 | 45,044 | 150,733 (0%) | 0% | 358.7 | 16,157,076 | American Depositary Shares |
| NOW Inc | Mr. Raymond W. Chang | VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.53 per share. | 10 Aug 2026 | 43,621 | 404,009 (0%) | 0% | 9.5 | 415,708 | Common stock |
| NOW Inc | Mr. Raymond W. Chang | VP and General Counsel | 10 Aug 2026 | 43,621 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| NOW Inc | Mr. Raymond W. Chang | VP and General Counsel | Sale of securities on an exchange or to another person at price $ 16.98 per share. | 10 Aug 2026 | 43,621 | 360,388 (0%) | 0% | 17.0 | 740,685 | Common stock |
| Procore Tech Inc | Mr. Craig F. Courtemanche, Jr | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 57.28 per share. | 10 Aug 2026 | 43,480 | 919,704 | - | 57.3 | 2,490,534 | Common Stock |
| Datadog Inc (Class A) | Mr. Alexis Le-Quoc | Director, Chief Technology Officer | 10 Aug 2026 | 43,224 | 553,029 (0%) | 0% | 0 | Class A Common Stock | ||
| Aeva Tech Inc | Mr. Mina Rezk | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 24.19 per share. | 10 Aug 2026 | 42,940 | 1,608,869 | - | 24.2 | 1,038,624 | Common Stock |
| Savers Value Village Inc | Mr. Mark Walsh | Director, CEO & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.41 per share. | 10 Aug 2026 | 42,059 | 89,422 | - | 1.4 | 59,303 | Common Stock |
| Savers Value Village Inc | Mr. Mark Walsh | Director, CEO & Director | 10 Aug 2026 | 42,059 | 540,800 | - | - | Stock Options (Right to Purchase) | ||
| Live Oak Bancshares Inc | Mr. William C. Losch, III | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2026 | 42,000 | 254,278 (0%) | 0% | - | Voting Common Stock | |
| Live Oak Bancshares Inc | Mr. William C. Losch, III | President | 10 Aug 2026 | 42,000 | 0 | - | - | Restricted Stock Units | ||
| NOW Inc | Mr. Mark B. Johnson | See Remarks | Sale of securities on an exchange or to another person at price $ 16.79 per share. | 10 Aug 2026 | 40,675 | 249,545 (0%) | 0% | 16.8 | 682,933 | Common stock |
| Mueller Water Products Inc - Ordinary Shares - Series A | Mr. Paul McAndrew | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 26.39 per share. | 10 Aug 2026 | 40,000 | 42,556 (0%) | 0% | 26.4 | 1,055,572 | Common Stock |
| CoreWeave Inc (Class A) | Mr. Brannin McBee | Chief Development Officer | 10 Aug 2026 | 40,000 | 3,517,227 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Mr. Brannin McBee | Chief Development Officer | 10 Aug 2026 | 40,000 | 40,000 | - | - | Class A Common Stock | ||
| Via Transportation Inc | Mr. Arnon Dinur | Director | Purchase of securities on an exchange or from another person at price $ 22.25 per share. | 10 Aug 2026 | 40,000 | 50,214 | - | 22.3 | 890,000 | - |
| Ameresco Inc (Class A) | Mr. Brian Cox | Director | Purchase of securities on an exchange or from another person at price $ 25.07 per share. | 10 Aug 2026 | 39,700 | 39,700 (0%) | 0% | 25.1 | 995,279 | Class A Common Stock |
| Replimune Grp Inc | Dr. Sushil Patel, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.97 per share. | 10 Aug 2026 | 39,341 | 708,151 (1%) | 0% | 13.0 | 510,253 | Common Stock |
| Sonida Senior Living Inc | Mr. Michael Simanovsky | Director, Ten Percent Owner | 10 Aug 2026 | 38,742 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Sonida Senior Living Inc | Mr. Michael Simanovsky | Director, Ten Percent Owner | 10 Aug 2026 | 38,742 | 38,742 | - | - | Series B Convertible Preferred Stock | ||
| Sonida Senior Living Inc | Mr. Michael Simanovsky | Director, Ten Percent Owner | 10 Aug 2026 | 38,742 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Sonida Senior Living Inc | Mr. Michael Simanovsky | Director, Ten Percent Owner | 10 Aug 2026 | 38,742 | 38,742 | - | - | Series A Convertible Preferred Stock | ||
| Aeva Tech Inc | Mr. Soroush Salehian Dardashti | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 23.86 per share. | 10 Aug 2026 | 38,622 | 1,546,210 | - | 23.9 | 921,699 | Common Stock |
| Cintas | Mr. James N. Rozakis | President & COO | 10 Aug 2026 | 35,995 | 35,995 | - | - | Stock Option (Right to Buy) | ||
| Cintas | Mr. Todd M. Schneider | Director, CEO and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 202.71 per share. | 10 Aug 2026 | 35,599 | 691,407 (0%) | 0% | 202.7 | 7,216,273 | Common Stock |
| Guardant Health Inc | Mr. Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 110.49 per share. | 10 Aug 2026 | 35,412 | 100,786 (0%) | 0% | 110.5 | 3,912,672 | Common Stock |
| Guardant Health Inc | Mr. Chris Freeman | Chief Commercial Officer | 10 Aug 2026 | 35,412 | 3,620 | - | - | Stock Option (Right to Buy) | ||
| Guardant Health Inc | Mr. Chris Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 169.63 per share. | 10 Aug 2026 | 35,364 | 82,787 (0%) | 0% | 169.6 | 5,998,926 | Common Stock |
| Popular Inc | Mr. Javier D. Ferrer | PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 175.43 per share. | 10 Aug 2026 | 35,000 | 96,478 (0%) | 0% | 175.4 | 6,140,155 | Common Stock Par Value $0.01 per share |
| Honest Co Inc (The ) | Ms. Andrea A. Turner | Director | Sale of securities on an exchange or to another person at price $ 5.30 per share. | 10 Aug 2026 | 34,396 | 282,304 | - | 5.3 | 182,299 | Common Stock |
| Protagonist Therapeutics Inc | Dr. Dinesh V. Patel, PhD | Director, President and CEO | 10 Aug 2026 | 34,239 | 125,000 | - | - | Stock Option (right to buy) | ||
| Protagonist Therapeutics Inc | Dr. Dinesh V. Patel, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 148.52 per share. | 10 Aug 2026 | 34,239 | 523,478 (1%) | 0% | 148.5 | 5,085,176 | Common Stock |
| Protagonist Therapeutics Inc | Dr. Dinesh V. Patel, PhD | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.58 per share. | 10 Aug 2026 | 34,239 | 557,717 (2%) | 0% | 21.6 | 738,878 | Common Stock |
| Allient Inc | Mr. Richard S. Warzala | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 113.96 per share. | 10 Aug 2026 | 33,944 | 1,499,958 (15%) | 0% | 114.0 | 3,868,228 | Common Stock |
| Braze Inc (Class A) | Ms. Astha Malik | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 27.65 per share. | 10 Aug 2026 | 33,656 | 278,138 | - | 27.6 | 930,588 | Class A Common Stock |
| NOW Inc | Mr. Raymond W. Chang | VP and General Counsel | 10 Aug 2026 | 32,617 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| NOW Inc | Mr. Raymond W. Chang | VP and General Counsel | Sale of securities on an exchange or to another person at price $ 16.98 per share. | 10 Aug 2026 | 32,617 | 360,388 (0%) | 0% | 17.0 | 553,837 | Common stock |
| NOW Inc | Mr. Raymond W. Chang | VP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.26 per share. | 10 Aug 2026 | 32,617 | 393,005 (0%) | 0% | 10.3 | 334,650 | Common stock |
| CoreWeave Inc (Class A) | Mr. Brannin McBee | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 90.55 per share. | 10 Aug 2026 | 31,682 | 335,099 | - | 90.5 | 2,868,729 | Class A Common Stock |
| Pure Storage Inc (Class A) | Mr. Charles H. Giancarlo | Director, CEO | Sale of securities on an exchange or to another person at price $ 98.50 per share. | 10 Aug 2026 | 30,800 | 1,645,897 (0%) | 0% | 98.5 | 3,033,800 | Class A Common Stock |
| Pure Storage Inc (Class A) | Mr. Charles H. Giancarlo | Director, CEO | Sale of securities on an exchange or to another person at price $ 99.27 per share. | 10 Aug 2026 | 30,601 | 1,615,296 (0%) | 0% | 99.3 | 3,037,761 | Class A Common Stock |
| 908 Devices Inc | Dr. Kevin J. Knopp, PhD | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 10.16 per share. | 10 Aug 2026 | 30,170 | 586,337 | - | 10.2 | 306,527 | Common Stock |
| Park Aerospace Corp | Mr. Brian E. Shore | Director, Board Chairman & CEO | Sale of securities on an exchange or to another person at price $ 37.09 per share. | 10 Aug 2026 | 30,000 | 621,369 (3%) | 0% | 37.1 | 1,112,700 | Common Stock |
| Gen Digital | Mr. Travis Michael Witteveen | Head of Products and Portfolio | Sale of securities on an exchange or to another person at price $ 29.42 per share. | 10 Aug 2026 | 30,000 | 496,545 (0%) | 0% | 29.4 | 882,558 | Common Stock |
| Phillips 66 | Mr. Brian M. Mandell | Executive Vice President | 10 Aug 2026 | 30,000 | 23,400 | - | - | Employee Stock Option (Right to Buy) | ||
| Phillips 66 | Mr. Brian M. Mandell | Executive Vice President | Sale of securities on an exchange or to another person at price $ 215.00 per share. | 10 Aug 2026 | 30,000 | 61,594 (0%) | 0% | 215 | 6,450,000 | Common Stock |
| Phillips 66 | Mr. Brian M. Mandell | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.70 per share. | 10 Aug 2026 | 30,000 | 91,594 (0%) | 0% | 74.7 | 2,241,000 | Common Stock |
| Honest Co Inc (The ) | Ms. Andrea A. Turner | Director | Sale of securities on an exchange or to another person at price $ 5.21 per share. | 10 Aug 2026 | 29,899 | 252,405 | - | 5.2 | 155,774 | Common Stock |
| Figure Technology Solutions | Mr. Michael Scott Cagney | Director, Ten Percent Owner | 10 Aug 2026 | 29,612 | 4,776,787 | - | - | Class B Common Stock | ||
| Figure Technology Solutions | Ms. June Ou | Director, Ten Percent Owner | 10 Aug 2026 | 29,612 | 4,776,787 | - | - | Class B Common Stock | ||
| Virtus Artificial Intelligence & Tech Opportunities Fund | Mr. Justin Kass | PM | Sale or transfer of securities back to the company at price $ 26.27 per share. | 10 Aug 2026 | 29,481 | 0 | - | 26.3 | 774,416 | Virtus Artificial Intelligence Opportunities Fund |
| Virtus Artificial Intelligence & Tech Opportunities Fund | Mr. Justin Kass | PM | Sale of securities on an exchange or to another person at price $ 26.27 per share. | 10 Aug 2026 | 29,481 | 0 | - | 26.3 | 774,416 | Virtus Artificial Intelligence Opportunities Fund |
| EVgo Inc (Class A) | Mr. Dennis G. Kish | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2026 | 29,312 | 277,627 | - | 0 | Class A Common Stock | |
| EVgo Inc (Class A) | Mr. Dennis G. Kish | President | 10 Aug 2026 | 29,312 | 0 | - | - | Restricted Stock Units | ||
| Maravai LifeSciences Holdings Inc (Class A) | Mr. Bernd Brust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.23 per share. | 10 Aug 2026 | 29,250 | 1,590,499 | - | 6.2 | 182,228 | Class A Common Stock |
| Materion Corp | Mr. Robert B. Toth | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 28,832 | 0 (0%) | 0% | 0 | Common Stock | |
| Materion Corp | Mr. Robert B. Toth | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 28,832 | 28,832 (0%) | 0% | 0 | Common Stock | |
| Sinclair Inc (Class A) | Mr. David B. Gibber | EVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 13.74 per share. | 10 Aug 2026 | 28,828 | 184,244 (0%) | 0% | 13.7 | 396,137 | Class A Common Stock |
| Charles River Labs | Mr. James C. Foster | Director | Sale of securities on an exchange or to another person at price $ 275.00 per share. | 10 Aug 2026 | 28,733 | 31,596 (0%) | 0% | 275 | 7,901,575 | Common Stock |
| Charles River Labs | Mr. James C. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 179.66 per share. | 10 Aug 2026 | 28,733 | 60,329 (0%) | 0% | 179.7 | 5,162,171 | Common Stock |
| Charles River Labs | Mr. James C. Foster | Director | 10 Aug 2026 | 28,733 | 0 | - | - | Stock Options (Right to Buy) | ||
| General Dynamics | Ms. Kimberly A. Kuryea | Senior Vice President & CFO | 10 Aug 2026 | 28,300 | 0 | - | - | Stock Options | ||
| General Dynamics | Ms. Kimberly A. Kuryea | Senior Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 223.93 per share. | 10 Aug 2026 | 28,300 | 115,381 (0%) | 0% | 223.9 | 6,337,219 | Common Stock |
| Guardant Health Inc | Mr. Chris Freeman | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.37 per share. | 10 Aug 2026 | 28,193 | 128,979 (0%) | 0% | 28.4 | 799,835 | Common Stock |
| Guardant Health Inc | Mr. Chris Freeman | Chief Commercial Officer | 10 Aug 2026 | 28,193 | 1,668 | - | - | Stock Option (Right to Buy) | ||
| ADTRAN Holdings Inc | Mr. Christoph Glingener | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2026 | 27,924 | 83,953 (0%) | 0% | 0 | Common Stock | |
| Chiron Real Estate Inc | Mr. Charles Fitzgerald | Director | Purchase of securities on an exchange or from another person at price $ 35.94 per share. | 10 Aug 2026 | 27,600 | 124,893 (0%) | 0% | 35.9 | 991,944 | Common Stock |
| EVgo Inc (Class A) | Ms. Francine Sullivan | Chief Legal Officer | 10 Aug 2026 | 27,358 | 0 | - | - | Restricted Stock Units | ||
| EVgo Inc (Class A) | Ms. Francine Sullivan | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2026 | 27,358 | 356,370 | - | 0 | Class A Common Stock | |
| Circle Internet Grp Inc (Class A) | Mr. Nikhil Chandhok | Chief Product & Tech. Officer | Sale of securities on an exchange or to another person at price $ 67.15 per share. | 10 Aug 2026 | 26,666 | 717,920 | - | 67.2 | 1,790,622 | Class A Common Stock |
| TTM Tech Inc | Mr. Dale Knecht | SVP Information Technology | Sale of securities on an exchange or to another person at price $ 142.00 per share. | 10 Aug 2026 | 26,198 | 40,138 (0%) | 0% | 142 | 3,720,116 | Common Stock |
| Neostellar Capital Corp | Mr. Mark D. Klein | Director, Chairman, CEO and President | Purchase of securities on an exchange or from another person at price $ 9.60 per share. | 10 Aug 2026 | 26,040 | 1,758,796 (9%) | 0% | 9.6 | 249,984 | Common Stock |
| Cerence Inc | Ms. Jennifer Salinas | EVP Chief Admin Officer | Sale of securities on an exchange or to another person at price $ 8.83 per share. | 10 Aug 2026 | 25,998 | 694,029 (1%) | 0% | 8.8 | 229,508 | Common Stock |
| Pegasystems Inc | Mr. Kenneth Stillwell | COO, CFO | 10 Aug 2026 | 25,920 | 25,920 | - | - | Stock Options | ||
| Pegasystems Inc | Mr. Kenneth Stillwell | COO, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.95 per share. | 10 Aug 2026 | 25,920 | 143,925 (0%) | 0% | 17.0 | 439,344 | Common stock |
| Clean Energy Fuels Corp | Mr. Barclay F. Corbus | Director, PRESIDENT AND CEO | Purchase of securities on an exchange or from another person at price $ 1.62 per share. | 10 Aug 2026 | 25,000 | 1,375,021 (0%) | 0% | 1.6 | 40,500 | Common Stock |
| Park Aerospace Corp | Mr. Brian E. Shore | Director, Board Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.44 per share. | 10 Aug 2026 | 25,000 | 646,369 (3%) | 0% | 14.4 | 361,000 | Common Stock |
| Park Aerospace Corp | Mr. Brian E. Shore | Director, Board Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.58 per share. | 10 Aug 2026 | 25,000 | 646,369 (3%) | 0% | 11.6 | 289,500 | Common Stock |
| Park Aerospace Corp | Mr. Brian E. Shore | Director, Board Chairman & CEO | 10 Aug 2026 | 25,000 | 0 | - | - | Right to buy | ||
| Park Aerospace Corp | Mr. Brian E. Shore | Director, Board Chairman & CEO | 10 Aug 2026 | 25,000 | 0 | - | - | Right to buy option | ||
| CoreWeave Inc (Class A) | Mr. Brannin McBee | Chief Development Officer | 10 Aug 2026 | 25,000 | 1,830,300 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Mr. Brannin McBee | Chief Development Officer | 10 Aug 2026 | 25,000 | 3,391,020 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Mr. Brannin McBee | Chief Development Officer | 10 Aug 2026 | 25,000 | 25,000 | - | - | Class A Common Stock | ||
| CoreWeave Inc (Class A) | Mr. Brannin McBee | Chief Development Officer | 10 Aug 2026 | 25,000 | 25,000 | - | - | Class A Common Stock | ||
| Live Oak Bancshares Inc | Mr. Renato Derraik | Chief Info./Digital Off., Bank | 10 Aug 2026 | 25,000 | 0 | - | - | Restricted Stock Units | ||
| Live Oak Bancshares Inc | Mr. Renato Derraik | Chief Info./Digital Off., Bank | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2026 | 25,000 | 29,243 (0%) | 0% | - | Voting Common Stock | |
| SPX Tech Inc | Mr. Robert B. Toth | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 24,892 | 24,892 (0%) | 0% | 0 | Common Stock | |
| SPX Tech Inc | Mr. Robert B. Toth | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 24,892 | 754 (0%) | 0% | 0 | Common Stock | |
| Circle Internet Grp Inc (Class A) | Mr. Nikhil Chandhok | Chief Product & Tech. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.81 per share. | 10 Aug 2026 | 23,333 | 744,586 | - | 25.8 | 602,225 | Class A Common Stock |
| Circle Internet Grp Inc (Class A) | Mr. Nikhil Chandhok | Chief Product & Tech. Officer | 10 Aug 2026 | 23,333 | 369,678 | - | - | Stock Option (Right to Buy) | ||
| Figma Inc Ordinary Shares | Mr. Daniel Hiller Rimer | Director | Other type of transaction at price $ 0.00 per share. | 10 Aug 2026 | 23,150 | 763,550 | - | - | Class A Common Stock | |
| Criteo S.A (ADR) | Mr. Connor McGogney | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2026 | 23,090 | 186,558 (0%) | 0% | 0 | Ordinary Shares | |
| Heartflow Inc | Mr. John C.M. Farquhar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.31 per share. | 10 Aug 2026 | 22,562 | 436,280 | - | 28.3 | 638,730 | Common Stock |
| ProFrac Holding Corp (Class A) | Mr. Matthew D. Wilks | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.44 per share. | 10 Aug 2026 | 22,481 | 502,097 | - | 5.4 | 122,366 | Class A common stock, par value $0.01 per share |
| NOW Inc | Mr. Mark B. Johnson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.53 per share. | 10 Aug 2026 | 21,985 | 312,205 (0%) | 0% | 9.5 | 209,517 | Common stock |
| NOW Inc | Mr. Mark B. Johnson | See Remarks | 10 Aug 2026 | 21,985 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| NOW Inc | Mr. Mark B. Johnson | See Remarks | Sale of securities on an exchange or to another person at price $ 16.79 per share. | 10 Aug 2026 | 21,985 | 290,220 (0%) | 0% | 16.8 | 369,128 | Common stock |
| General Dynamics | Ms. Kimberly A. Kuryea | Senior Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 395.59 per share. | 10 Aug 2026 | 21,557 | 93,824 (0%) | 0% | 395.6 | 8,527,734 | Common Stock |
| BeiGene Ltd (ADR) | Mr. John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 359.50 per share. | 10 Aug 2026 | 21,254 | 129,479 (0%) | 0% | 359.5 | 7,640,826 | American Depositary Shares |
| Park Aerospace Corp | Mr. Brian E. Shore | Director, Board Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.80 per share. | 10 Aug 2026 | 21,250 | 667,619 (3%) | 0% | 12.8 | 272,000 | Common Stock |
| Park Aerospace Corp | Mr. Brian E. Shore | Director, Board Chairman & CEO | 10 Aug 2026 | 21,250 | 8,750 | - | - | Right to buy option | ||
| BeiGene Ltd (ADR) | Mr. John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 358.41 per share. | 10 Aug 2026 | 20,899 | 14,102 (0%) | 0% | 358.4 | 7,490,448 | American Depositary Shares |
| Merck & Company | Mr. Richard R. DeLuca, Jr | EVP&Pres, Merck Animal Heallth | Sale of securities on an exchange or to another person at price $ 130.43 per share. | 10 Aug 2026 | 20,784 | 134,703 (0%) | 0% | 130.4 | 2,710,951 | Common Stock |
| Harmonic Inc | Mr. Walter F. Jankovic | Chief Financial Officer | 10 Aug 2026 | 20,614 | 20,614 | - | - | Restricted Stock Units | ||
| Veeco Instruments Inc | Mr. John P. Kiernan | SVP & CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 50.42 per share. | 10 Aug 2026 | 20,256 | 83,546 (0%) | 0% | 50.4 | 1,021,308 | Common Stock |
| Insteel Ind Inc | Mr. H. O. Woltz,III | Director, Chairman, President and CEO | 10 Aug 2026 | 20,132 | 20,132 | - | - | Option (right to buy) | ||
| Mirum Pharma Inc | Mr. Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | 10 Aug 2026 | 20,000 | 88,487 | - | - | Employee Stock Option (right to buy) | ||
| Mirum Pharma Inc | Mr. Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 10 Aug 2026 | 20,000 | 214,309 (0%) | 0% | 2.9 | 58,720 | Common Stock |
| Spok Holdings Inc | Ms. Sharon Woods Keisling | Corporate Secretary, Treasurer | Sale of securities on an exchange or to another person at price $ 11.30 per share. | 10 Aug 2026 | 20,000 | 6,036 (0%) | 0% | 11.3 | 225,940 | Common Stock |
| Owens Corning | Mr. Jonathan Mark Collins | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 153.80 per share. | 10 Aug 2026 | 19,504 | 19,504 (0%) | 0% | 153.8 | 2,999,715 | $.01 Par Value Common |
| Rapport Therapeutics Inc | Mr. Abraham N. Ceesay, M.B.A. | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 48.04 per share. | 10 Aug 2026 | 19,500 | 491,902 | - | 48.0 | 936,846 | Common Stock |
| Encompass Health Corp | Mr. Douglas E. Coltharp | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 125.38 per share. | 10 Aug 2026 | 18,869 | 50,508 (0%) | 0% | 125.4 | 2,365,795 | Encompass Health Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 27.98 per share. | 10 Aug 2026 | 18,750 | 181,641 | - | 28.0 | 524,533 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | 10 Aug 2026 | 18,750 | 51,752 | - | - | Stock Option (Right to Buy) | ||
| Bicara Therapeutics Inc | Mr. Ryan Cohlhepp | Director, President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. | 10 Aug 2026 | 18,750 | 200,391 | - | 3.8 | 71,059 | Common Stock |
| Datadog Inc (Class A) | Mr. Alexis Le-Quoc | Director, Chief Technology Officer | 10 Aug 2026 | 18,750 | 2,335,552 | - | - | Class B Common Stock | ||
| Datadog Inc (Class A) | Mr. Alexis Le-Quoc | Director, Chief Technology Officer | 10 Aug 2026 | 18,750 | 150,000 | - | - | Stock Option (Right to Buy) | ||
| SharkNinja Inc | Mr. Neil Shah | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 184.58 per share. | 10 Aug 2026 | 18,721 | 42,378 | - | 184.6 | 3,455,522 | Ordinary Shares |
| Live Oak Bancshares Inc | Mr. William C. Losch, III | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.23 per share. | 10 Aug 2026 | 18,665 | 235,613 (0%) | 0% | 42.2 | 788,223 | Voting Common Stock |
| Intuitive Machines Inc (Class A) | Dr. Kamal Seyed Ghaffarian, PhD | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.68 per share. | 10 Aug 2026 | 18,664 | 3,494,768 | - | 16.7 | 311,362 | Class A Common Stock |
| Pegasystems Inc | Mr. Kenneth Stillwell | COO, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.93 per share. | 10 Aug 2026 | 18,292 | 125,633 (0%) | 0% | 32.9 | 602,356 | Common stock |
| Frontdoor Inc | Mr. Evan Iverson | SVP & Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 85.50 per share. | 10 Aug 2026 | 18,190 | 214 (0%) | 0% | 85.5 | 1,555,245 | Common Stock |
| Allient Inc | Mr. Richard S. Warzala | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 113.52 per share. | 10 Aug 2026 | 18,176 | 1,533,902 (15%) | 0% | 113.5 | 2,063,280 | Common Stock |
| Cintas | Mr. David Brock Denton | EVP, Secretary & Gen Counsel | 10 Aug 2026 | 17,999 | 17,999 | - | - | Stock Option (Right to Buy) | ||
| Medpace Holdings Inc | Mr. August J. Troendle, M.D. | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 605.11 per share. | 10 Aug 2026 | 17,610 | 615,802 (1%) | 0% | 605.1 | 10,655,987 | Common Stock |
| Guardant Health Inc | Mr. Chris Freeman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 170.24 per share. | 10 Aug 2026 | 17,413 | 65,374 (0%) | 0% | 170.2 | 2,964,401 | Common Stock |
| Allient Inc | Mr. Richard S. Warzala | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 112.81 per share. | 10 Aug 2026 | 17,028 | 1,552,078 (16%) | 0% | 112.8 | 1,921,004 | Common Stock |
| Cheesecake Factory Inc | Mr. David M. Gordon | PRESIDENT | Sale of securities on an exchange or to another person at price $ 109.98 per share. | 10 Aug 2026 | 16,866 | 41,959 (0%) | 0% | 110.0 | 1,854,923 | Common Stock |
| Corcept Therapeutics Inc | Dr. William Guyer, Pharm.D. | Chief Development Officer | 10 Aug 2026 | 16,300 | 110,000 | - | - | Stock Option (right to buy) | ||
| Corcept Therapeutics Inc | Dr. William Guyer, Pharm.D. | Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.65 per share. | 10 Aug 2026 | 16,300 | 20,285 (0%) | 0% | 21.7 | 352,895 | Common Stock |
| Aeva Tech Inc | Mr. Soroush Salehian Dardashti | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 24.12 per share. | 10 Aug 2026 | 16,217 | 1,235,105 | - | 24.1 | 391,123 | Common Stock |
| biote Corp (Class A) | Mr. Marc D. Beer | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 1.55 per share. | 10 Aug 2026 | 16,000 | 239,744 | - | 1.6 | 24,800 | Class A Common Stock |
| Cintas | Mr. Scott D. Farmer | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 202.71 per share. | 10 Aug 2026 | 15,923 | 87,899 (0%) | 0% | 202.7 | 3,227,751 | Common Stock |
| BeiGene Ltd (ADR) | Mr. John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 357.67 per share. | 10 Aug 2026 | 15,869 | 195,777 (0%) | 0% | 357.7 | 5,675,864 | American Depositary Shares |
| Everspin Tech Inc | Mr. Vikas Choudhary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2026 | 15,693 | 15,693 (0%) | 0% | 0 | Common Stock | |
| Cisco | Mr. Charles H. Robbins | Director, Chair and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.44 per share. | 10 Aug 2026 | 15,655 | 624,337 (0%) | 0% | 121.4 | 1,901,102 | Common Stock |
| Life360 Inc | Ms. Brit Morin | Director | Sale of securities on an exchange or to another person at price $ 65.00 per share. | 10 Aug 2026 | 15,582 | 14,340 | - | 65 | 1,012,830 | Common stock |
| BeiGene Ltd (ADR) | Mr. John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 357.63 per share. | 10 Aug 2026 | 15,396 | 35,001 (0%) | 0% | 357.6 | 5,506,147 | American Depositary Shares |
| Aeva Tech Inc | Mr. Soroush Salehian Dardashti | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 24.27 per share. | 10 Aug 2026 | 15,377 | 1,530,833 | - | 24.3 | 373,255 | Common Stock |
| Omada Health Inc | Mr. Steve Cook | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 10 Aug 2026 | 15,235 | 187,209 | - | 25.0 | 381,350 | Common Stock |
| Heritage Insurance Holdings Inc | Mr. Timothy Moura | See Remarks | Sale of securities on an exchange or to another person at price $ 32.49 per share. | 10 Aug 2026 | 15,104 | 144,941 (0%) | 0% | 32.5 | 490,681 | Common Stock |
| Cheesecake Factory Inc | Mr. David M. Gordon | PRESIDENT | Sale of securities on an exchange or to another person at price $ 110.08 per share. | 10 Aug 2026 | 15,084 | 26,875 (0%) | 0% | 110.1 | 1,660,447 | Common Stock |
| Extreme Networks Inc | Mr. Rajendra Khanna | Director | Sale of securities on an exchange or to another person at price $ 24.20 per share. | 10 Aug 2026 | 15,000 | 195,062 (0%) | 0% | 24.2 | 363,002 | Common Stock |
| EVgo Inc (Class A) | Mr. Dennis G. Kish | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.59 per share. | 10 Aug 2026 | 14,914 | 262,713 | - | 1.6 | 23,713 | Class A Common Stock |
| CoreWeave Inc (Class A) | Mr. Brannin McBee | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 89.70 per share. | 10 Aug 2026 | 14,765 | 12,086 | - | 89.7 | 1,324,443 | Class A Common Stock |
| Nextracker Inc (Class A) | Mr. Daniel S. Shugar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 102.39 per share. | 10 Aug 2026 | 14,697 | 924,070 | - | 102.4 | 1,504,826 | Common Stock |
| BeiGene Ltd (ADR) | Mr. John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 361.47 per share. | 10 Aug 2026 | 14,569 | 89,454 (0%) | 0% | 361.5 | 5,266,268 | American Depositary Shares |
| Xos Inc | Mr. Dakota Semler | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.70 per share. | 10 Aug 2026 | 14,538 | 803,447 | - | 2.7 | 39,253 | Common Stock |
| Aeva Tech Inc | Mr. Soroush Salehian Dardashti | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 24.54 per share. | 10 Aug 2026 | 14,297 | 1,220,808 | - | 24.5 | 350,847 | Common Stock |
| Rapport Therapeutics Inc | Mr. Abraham N. Ceesay, M.B.A. | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 45.97 per share. | 10 Aug 2026 | 14,171 | 523,436 | - | 46.0 | 651,492 | Common Stock |
| BeiGene Ltd (ADR) | Mr. John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 359.12 per share. | 10 Aug 2026 | 14,102 | 0 (0%) | 0% | 359.1 | 5,064,252 | American Depositary Shares |
| Happen Inc | Mr. Andrew LaBenne | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.37 per share. | 10 Aug 2026 | 13,929 | 221,026 (0%) | 0% | 19.4 | 269,823 | Common Stock |
| Biodesix Inc | Mr. Jack W. Schuler | Ten Percent Owner, Emeritus Director | Purchase of securities on an exchange or from another person at price $ 24.25 per share. | 10 Aug 2026 | 13,900 | 527,110 | - | 24.2 | 337,029 | Common Stock |
| Biodesix Inc | Mr. Jack W. Schuler | Ten Percent Owner, Emeritus Director | Purchase of securities on an exchange or from another person at price $ 24.01 per share. | 10 Aug 2026 | 13,700 | 540,810 | - | 24.0 | 328,911 | Common Stock |
| BeiGene Ltd (ADR) | Mr. John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 359.32 per share. | 10 Aug 2026 | 13,695 | 112,104 (0%) | 0% | 359.3 | 4,920,844 | American Depositary Shares |
| Xos Inc | Mr. Giordano Sordoni | Director, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.70 per share. | 10 Aug 2026 | 13,663 | 1,602,828 | - | 2.7 | 36,890 | Common Stock |
| Timken Co. | Mr. Richard G. Kyle | Director | Sale of securities on an exchange or to another person at price $ 126.63 per share. | 10 Aug 2026 | 13,637 | 183,724 (0%) | 0% | 126.6 | 1,726,853 | Common Stock |
| Stride Inc | Mr. Robert E. Knowling, Jr | Director, Chief Executive Officer | 10 Aug 2026 | 13,633 | 13,633 | - | - | Restricted Stock Right | ||
| Omada Health Inc | Mr. Steve Cook | Chief Financial Officer | 10 Aug 2026 | 13,499 | 236,196 | - | - | Stock Option (Right to Buy) | ||
| Omada Health Inc | Mr. Steve Cook | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.28 per share. | 10 Aug 2026 | 13,499 | 200,708 | - | 8.3 | 111,772 | Common Stock |
| BeiGene Ltd (ADR) | Mr. John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 363.45 per share. | 10 Aug 2026 | 13,403 | 64,483 (0%) | 0% | 363.5 | 4,871,344 | American Depositary Shares |
| CoreWeave Inc (Class A) | Mr. Brannin McBee | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 88.70 per share. | 10 Aug 2026 | 13,149 | 26,851 | - | 88.7 | 1,166,344 | Class A Common Stock |
| Huntington Ingalls | Mr. Christopher D. Kastner | Director, Director, President & CEO | Sale of securities on an exchange or to another person at price $ 324.92 per share. | 10 Aug 2026 | 13,070 | 11,223 (0%) | 0% | 324.9 | 4,246,704 | Common Stock |
| Frontdoor Inc | Mr. Jeffrey A. Fiarman | SVP & Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 85.11 per share. | 10 Aug 2026 | 13,000 | 20,023 (0%) | 0% | 85.1 | 1,106,434 | Common Stock |
| Procore Tech Inc | Mr. Craig F. Courtemanche, Jr | Director, Chairman of the Board | Sale of securities on an exchange or to another person at price $ 56.54 per share. | 10 Aug 2026 | 12,642 | 963,184 | - | 56.5 | 714,779 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ivan Hyep | Chief Financial Officer | 10 Aug 2026 | 12,500 | 26,336 | - | - | Stock Option (Right to Buy) | ||
| Bicara Therapeutics Inc | Mr. Ivan Hyep | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. | 10 Aug 2026 | 12,500 | 142,355 | - | 3.8 | 47,373 | Common Stock |
| Bicara Therapeutics Inc | Mr. Ivan Hyep | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 27.97 per share. | 10 Aug 2026 | 12,500 | 129,855 | - | 28.0 | 349,591 | Common Stock |
| CoreWeave Inc (Class A) | Mr. Brannin McBee | Chief Development Officer | 10 Aug 2026 | 12,500 | 436,205 | - | - | Class B Common Stock | ||
| CoreWeave Inc (Class A) | Mr. Brannin McBee | Chief Development Officer | 10 Aug 2026 | 12,500 | 12,500 | - | - | Class A Common Stock | ||
| Magnite Inc | Mr. Brian Gephart | CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 24.68 per share. | 10 Aug 2026 | 12,479 | 106,117 (0%) | 0% | 24.7 | 307,982 | Common Stock |
| Figma Inc Ordinary Shares | Mr. Daniel Hiller Rimer | Director | Sale of securities on an exchange or to another person at price $ 25.39 per share. | 10 Aug 2026 | 12,475 | 786,700 | - | 25.4 | 316,740 | Class A Common Stock |
| BeiGene Ltd (ADR) | Mr. John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 356.62 per share. | 10 Aug 2026 | 12,418 | 211,646 (0%) | 0% | 356.6 | 4,428,482 | American Depositary Shares |
| Zevra Therapeutics Inc | Mr. Corey Watton | Director | 10 Aug 2026 | 12,300 | 46,500 | - | - | Stock Option (right to buy) | ||
| Zevra Therapeutics Inc | Mr. Corey Watton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.97 per share. | 10 Aug 2026 | 12,300 | 14,100 (0%) | 0% | 5.0 | 61,131 | Common Stock |
| Zevra Therapeutics Inc | Mr. Corey Watton | Director | Sale of securities on an exchange or to another person at price $ 11.25 per share. | 10 Aug 2026 | 12,300 | 1,800 (0%) | 0% | 11.3 | 138,377 | Common Stock |
| ATN Intl Inc | Mr. Cornelius B. Prior,Jr | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 12,000 | 3,982,303 (24%) | 0% | 0 | Common Stock | |
| California Resources Corp - Ordinary Shares - New | Mr. Jay A. Bys | EVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 54.00 per share. | 10 Aug 2026 | 11,907 | 147,517 (0%) | 0% | 54 | 642,978 | Common Stock |
| Mirum Pharma Inc | Mr. Christopher Peetz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 98.51 per share. | 10 Aug 2026 | 11,683 | 202,626 (0%) | 0% | 98.5 | 1,150,892 | Common Stock |
| Ranger Energy Services Inc (Class A) | Mr. J. Matt Hooker | Exec VP, Well Services | Sale of securities on an exchange or to another person at price $ 16.63 per share. | 10 Aug 2026 | 11,620 | 87,528 (1%) | 0% | 16.6 | 193,241 | Class A Common Stock |
| BeiGene Ltd (ADR) | Mr. John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 362.34 per share. | 10 Aug 2026 | 11,568 | 77,886 (0%) | 0% | 362.3 | 4,191,548 | American Depositary Shares |
| Corcept Therapeutics Inc | Dr. William Guyer, Pharm.D. | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 113.18 per share. | 10 Aug 2026 | 11,530 | 8,755 (0%) | 0% | 113.2 | 1,304,933 | Common Stock |
| Replimune Grp Inc | Ms. Emily Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.97 per share. | 10 Aug 2026 | 11,448 | 225,108 (0%) | 0% | 13.0 | 148,481 | Common Stock |
| Replimune Grp Inc | Dr. Konstantinos Xynos, M.D. | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.97 per share. | 10 Aug 2026 | 11,447 | 224,215 (0%) | 0% | 13.0 | 148,468 | Common Stock |
| Live Oak Bancshares Inc | Mr. Renato Derraik | Chief Info./Digital Off., Bank | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.23 per share. | 10 Aug 2026 | 11,111 | 18,132 (0%) | 0% | 42.2 | 469,218 | Voting Common Stock |
| Merck & Company | Mr. Richard R. DeLuca, Jr | EVP&Pres, Merck Animal Heallth | Sale of securities on an exchange or to another person at price $ 131.61 per share. | 10 Aug 2026 | 11,099 | 110,767 (0%) | 0% | 131.6 | 1,460,770 | Common Stock |
| Immunome Inc | Mr. Isaac Barchas, J.D. | Director | Sale of securities on an exchange or to another person at price $ 27.25 per share. | 10 Aug 2026 | 11,048 | 92,211 | - | 27.3 | 301,058 | Common Stock |
| Cheesecake Factory Inc | Mr. David M. Gordon | PRESIDENT | 10 Aug 2026 | 11,040 | 0 | - | - | Employee Stock Option (right to buy) | ||
| Cheesecake Factory Inc | Mr. David M. Gordon | PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.16 per share. | 10 Aug 2026 | 11,040 | 52,999 (0%) | 0% | 40.2 | 443,366 | Common Stock |
| Tactile Systems Tech Inc | Ms. Sheri Louise Dodd | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 29.44 per share. | 10 Aug 2026 | 10,978 | 232,907 (1%) | 0% | 29.4 | 323,243 | Common Stock |
| EVgo Inc (Class A) | Ms. Francine Sullivan | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.59 per share. | 10 Aug 2026 | 10,766 | 345,604 | - | 1.6 | 17,118 | Class A Common Stock |
| Cintas | Mr. James N. Rozakis | President & COO | Grant, award, or other acquisition of securities at price $ 202.71 per share. | 10 Aug 2026 | 10,695 | 285,808 (0%) | 0% | 202.7 | 2,167,983 | Common Stock |
| Cintas | Mr. Scott Garula | EVP & CFO | Grant, award, or other acquisition of securities at price $ 202.71 per share. | 10 Aug 2026 | 10,695 | 108,453 (0%) | 0% | 202.7 | 2,167,983 | Common Stock |
| Datadog Inc (Class A) | Mr. Alexis Le-Quoc | Director, Chief Technology Officer | 10 Aug 2026 | 10,688 | 563,717 (0%) | 0% | 0 | Class A Common Stock | ||
| Take-Two Interactive Software | Mr. Strauss Zelnick | Director, Chairman, CEO | Sale of securities on an exchange or to another person at price $ 252.60 per share. | 10 Aug 2026 | 10,402 | 173,979 (0%) | 0% | 252.6 | 2,627,545 | Common Stock |
| CoreWeave Inc (Class A) | Mr. Brannin McBee | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 91.60 per share. | 10 Aug 2026 | 10,353 | 324,746 | - | 91.6 | 948,329 | Class A Common Stock |
| Harmonic Inc | Mr. Timothy C. Chu | General Counsel & SVP, HR | 10 Aug 2026 | 10,307 | 10,307 | - | - | Restricted Stock Units | ||
| Veeco Instruments Inc | Mr. John P. Kiernan | SVP & CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 51.29 per share. | 10 Aug 2026 | 10,236 | 73,310 (0%) | 0% | 51.3 | 525,004 | Common Stock |
| Immunome Inc | Mr. Isaac Barchas, J.D. | Director | Sale of securities on an exchange or to another person at price $ 26.07 per share. | 10 Aug 2026 | 10,125 | 62,291 | - | 26.1 | 263,959 | Common Stock |
| Iovance Biotherapeutics Inc | Mr. Daniel Gordon Kirby | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2026 | 10,001 | 156,947 (0%) | 0% | 0 | Common Stock | |
| Iovance Biotherapeutics Inc | Mr. Daniel Gordon Kirby | Chief Commercial Officer | 10 Aug 2026 | 10,001 | 60,003 | - | - | Restricted Stock Units | ||
| Take-Two Interactive Software | Mr. Strauss Zelnick | Director, Chairman, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 10,000 | 10,000 (0%) | 0% | 0 | Common Stock | |
| Take-Two Interactive Software | Mr. Strauss Zelnick | Director, Chairman, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2026 | 10,000 | 152,314 (0%) | 0% | 0 | Common Stock | |
| Abercrombie & Fitch Co. (Class A) | Mr. Scott D. Lipesky | EVP and COO | Sale of securities on an exchange or to another person at price $ 115.00 per share. | 10 Aug 2026 | 10,000 | 152,534 (0%) | 0% | 115 | 1,150,000 | Class A Common Stock |
| Frontdoor Inc | Ms. Kathryn M. Collins | SVP & Chief Revenue Officer | 10 Aug 2026 | 10,000 | 12,299 | - | - | Employee Stock Options (Right to Buy) | ||
| Frontdoor Inc | Ms. Kathryn M. Collins | SVP & Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 88.98 per share. | 10 Aug 2026 | 10,000 | 20,322 (0%) | 0% | 89.0 | 889,800 | Common Stock |
| Frontdoor Inc | Ms. Kathryn M. Collins | SVP & Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.42 per share. | 10 Aug 2026 | 10,000 | 30,322 (0%) | 0% | 26.4 | 264,200 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.